As of press time, Jinxin Reproduction rose 6.98% to HK $6.44; China Mengniu Dairy rose 4.5% to HK $37.2; Eli Palace rose 4.49% to HK $0.465; and Baycom Medical-B rose 3.72% to HK $5.30.
About Jinxin Reproductive Company: Jinxin Reproductive Medical Group Co., Ltd. is a Chinese company mainly providing assisted reproductive services. The company operates through three business units. Assisted reproductive services mainly provide two treatment options for patients: artificial fertilization (AI) and in vitro fertilization (IVF). The management service department provides common management services to Jinjiang Reproductive Center and Jinxin Fertility Center. The auxiliary medical service department mainly provides medical services in the fields of gynecology, urology and internal medicine through Shenzhen Zhongshan Hospital. The company mainly operates in China and the United States.
About China Mengniu Dairy: China China Mengniu Dairy Co., Ltd. is an investment holding company mainly engaged in the production and sales of quality dairy products in China. Its products include liquid milk products (such as milk drinks and yogurt), ice cream, milk powder and other products (such as cheese). The company's subsidiaries include Mengniu (China) Investment Co., Ltd., China Mengniu International Co., Ltd. And Zhipu Mill Co., Ltd. Through its subsidiaries, the company is also engaged in the production and sale of plant-based beverages.
About Aidi Palace: Aidigong Maternal and Child Health Co., Ltd. (formerly known as Tongjia International Health Industry Group Co., Ltd.) is a Hong Kong investment holding company mainly engaged in health-related business. The company operates through two major divisions. The health industry division is engaged in natural health food, medical anti-aging and health maintenance base, medical and health industry investment management business. The investment and financing division is engaged in investment and financing.
The above content is sorted out by Securities Star according to public information. If you have any questions, please contact us.